BNET Industries
Last Fiscal Year Sales:$75.5M
- Public
- US
Dow Jones Description
The only thing generic about Interpharm is its medication. Founded in 2003 and headquartered in Hauppauge, NY, Interpharm Holdings, Inc. (AMEX: IPA) is a manufacturer of over-the-counter and generic prescription medications. It focuses on six drug families: scheduled narcotics, female hormone products, special release medications, softgel, liquid products and those medications that are currently coming off patent. Its 25 products include hydrocodone, acetaminophen and ibuprofen. It employs about 485 people and it had 2005 revenue of $39.9 million. In June 2006, the company closed its $10 million capital financing with Tullis-Dickerson Capital Financing III, L.P.
Number of Employees 500
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
News & Analysis
Filter by
interpharm holdings inc. - All News and Analysis
Interpharm Launches Generic Equivalent of Bactrim® Antibiotic
HAUPPAUGE, N.Y. -- Interpharm Holdings Inc. (AMEX: IPA) today announced the launch of Sulfamethoxazole and Trimethoprim ("SMT") single and double strength tablets, which are sold under the name BactrimR. SMT is a widely used antibiotic used to treat infections such as urinary tract infections, bronchitis, ear infections otitis, traveler's diarrhea,...
Interpharm Chairman and Chief Executive Officer Dr. Maganlal K. Sutaria Named a Recipient of Ernst & Young Entrepreneur of the Year 2004 Award
COMMACK, N.Y. -- Dr. Maganlal K. Sutaria, Chairman and Chief Executive Officer of Interpharm Holdings, Inc. (Amex: IPA), a manufacturer and distributor of generic pharmaceutical drugs, received the Ernst & Young Entrepreneur Of The YearR 2004 award in the manufacturing category for the Metropolitan New York Area. The awards banquet...
- 1
Industry Transcripts by Seeking Alpha
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes


